Quantcast
Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

Memorial Day Sale: Dividend.com Premium Price Slashed — Redeem Now

Dividend logo

The news from Pfizer Inc. (PFE ) at the end of last November landed like a bomb.

The New York-based pharmaceutical giant announced that it would buy Botox manufacturer Allergan Plc (AGN ) in a deal worth $160 billion, making the combined company the largest drugmaker in the world.

A Complex Merger

However, the size of the deal – or even the size of the new corporate behemoth – wasn’t what made it notable. The acquisition involved a complicated legal dance in which Allergan would technically buy Pfizer and the company’s headquarters would be moved to Ireland, even though the new company would actually be run by Pfizer executives in New York.

To read the Full Story, Go Premium or Log In

Popular Articles

Premium Shutterstock 593856878%20%281%29
News

The Market Wrap For May 26: Game On!

Politics – or in this case, the lack of – continues to be a primary driver of the market’s...

News

Trending: U.S.-Saudi Arabia Weapons Deal Drives Defense Stocks

Dividend.com analyzes the search patterns of our visitors each week. By sharing these trends with...

Dividend Investing Ideas Center

Critical Facts You Need to Know About Preferred Stocks

Have you ever wished for the safety of bonds, but the return potential of common stocks? If so,...